134 related articles for article (PubMed ID: 7567012)
1. Positron emission tomography in the detection of residual laryngeal carcinoma.
Austin JR; Wong FC; Kim EE
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):404-7. PubMed ID: 7567012
[TBL] [Abstract][Full Text] [Related]
2. Therapy evaluation of laryngeal carcinomas by tyrosine-pet.
De Boer JR; Pruim J; Burlage F; Krikke A; Tiebosch AT; Albers FW; Vaalburg W; Van Der Laan BF
Head Neck; 2003 Aug; 25(8):634-44. PubMed ID: 12884346
[TBL] [Abstract][Full Text] [Related]
3. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Reisser C; Haberkorn U; Dimitrakopoulou-Strauss A; Seifert E; Strauss LG
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):272-6. PubMed ID: 7873142
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
[TBL] [Abstract][Full Text] [Related]
6. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W
Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Pretreatment and 3-Month
Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
[TBL] [Abstract][Full Text] [Related]
10. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
[TBL] [Abstract][Full Text] [Related]
11. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
12. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
[TBL] [Abstract][Full Text] [Related]
14. Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.
Horiuchi C; Taguchi T; Yoshida T; Nishimura G; Kawakami M; Tanigaki Y; Matsuda H; Mikami Y; Oka T; Inoue T; Tsukuda M
Auris Nasus Larynx; 2008 Mar; 35(1):103-8. PubMed ID: 17825512
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
17. PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
Sistonen HJ; Ilmarinen T; Atula T; Aro K; Schildt J; Markkola A
BMC Cancer; 2023 Apr; 23(1):358. PubMed ID: 37072716
[TBL] [Abstract][Full Text] [Related]
18. Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.
Rousset J; Abgral R; Chinellato S; Garetier M; Barberot C; Valette G; Potard G; Le Bivic T; Salaun PY
Head Neck; 2013 Jul; 35(7):E202-4. PubMed ID: 22619005
[TBL] [Abstract][Full Text] [Related]
19. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Case LD
Cancer J Sci Am; 1997; 3(6):353-7. PubMed ID: 9403048
[TBL] [Abstract][Full Text] [Related]
20. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
